Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.
about
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.Calorie restriction and cancer prevention: metabolic and molecular mechanisms.Cancer chemoprevention.Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer.Cancer prevention studies in p53-deficient mice.Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugsLoss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceDFMO: targeted risk reduction therapy for colorectal neoplasia.BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.Genistein chemoprevention of prostate cancer in TRAMP miceDetoxifying cancer causing agents to prevent cancer.Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life.Arecanut as an emerging etiology of oral cancers in IndiaThe role of skin painting in predicting lung cancer.Novel Transgenic Mouse Model for Studying Human Serum Albumin as a Biomarker of Carcinogenic ExposureUltraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesisShort-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCGTumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer.Extremely low-frequency electromagnetic fields cause DNA strand breaks in normal cells.Low-dose radiation therapy of cancer: role of immune enhancement.Selectively starving cancer cells through dietary manipulation: methods and clinical implications.Modeling cutaneous squamous carcinoma development in the mouseChemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.Dietary Inflammatory Index and Risk of Colorectal Adenoma Recurrence: A Pooled Analysis.Evaluation of Elephantopus scaber on the inhibition of chemical carcinogenesis and tumor development in mice.Cytotoxic activity of aqueous extracts of Anogeissus leiocarpus and Terminalia avicennioides root barks against Ehrlich ascites carcinoma cells.Investigation of the extracts from Bidens pilosa Linn. var. radiata Sch. Bip. for antioxidant activities and cytotoxicity against human tumor cells.(-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against UVB-induced damage in HaCaT keratinocytes.Rutin Ameliorates Cyclophosphamide-induced Reproductive Toxicity in Male RatsTumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse model.Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.Chemopreventive effects of the juice of Vitis coignetiae Pulliat on two-stage mouse skin carcinogenesis.Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts.Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma.
P2860
Q30658549-A04584F8-927E-4762-AF99-B332557995E9Q30950997-6216F212-8F38-402F-841E-49F9B3B0B7E4Q33693451-B1EC959C-21E3-4EF5-B8D5-C4797447CC1AQ33809683-C3AACCA6-993A-424A-ADF6-AB0856DE03D2Q33959136-AA3196E1-A51C-4994-8E18-CE76E8C67325Q34160192-BBF0AB50-0D7B-4A36-A52E-5A4718E94BFFQ34632129-044B57C3-B008-4EB7-B316-89FC448C04CDQ35034369-C856925F-8F5E-41C8-92B6-9EEE01FAA09FQ35583635-7D391800-6EC5-4AA2-A08D-C6865759E912Q35641332-715E499B-5D26-46F4-A25D-41BF613681E2Q35699557-F9048061-ED16-409F-B3A7-AFEB2F75065CQ35702433-DA6417C6-C311-49E2-8DBC-D130202AFB6EQ36193834-4BF3F5BB-76A0-4B10-8B4D-D6492840F32DQ36228132-DA2ACABB-6ABC-4D48-8588-D728EEF9C583Q36895451-FBADEC7D-83AF-47B5-AE4C-BBBF0D8C947AQ36905461-0B2A08BD-3CC3-4C7F-A80F-8C99254F127CQ36989955-16F0A69D-5E1F-4FD6-90CD-952F8692836BQ37146692-D16AEA49-CB7A-4F16-B382-934B2E3CB1B2Q37424846-13A2BFC7-5AE0-49A4-A241-CB7905D58510Q37467514-6C5EE28B-85AD-47C1-8313-24AD8348D71BQ37501080-74760257-68A6-42BB-AC35-E33E817BAF30Q37873474-B3806BF2-B559-4A2E-AC67-048C77699E4CQ38120308-2077EFA0-F9FC-42CC-9504-301706945A9DQ38245726-9C0CB7F4-9A13-4EC4-ACC5-3A28CBB28261Q38728458-8CBED44E-AC3A-4AE0-B5E2-AD5E527D6742Q38769639-894B3B44-0E27-4041-9816-D7085F3D4CCEQ39019900-F0F65FAF-25BB-4DAD-8B0B-2F05B395FC44Q39098485-B9B8B3A4-7615-480E-89F1-35F42D959AB0Q39387273-A1D31DAF-26F1-43A8-81F2-E08AFB99E792Q40062609-C6CB5E66-9719-4117-ABCB-EB1C7C798F13Q41775772-6F7C2E87-F96A-48A0-9540-D1A38007E321Q42463337-25C58815-406B-42BB-983A-3E4A292CFE6DQ42479611-D11BC69A-0A30-4CCD-BC4B-64DDC5649A07Q44648517-7799F405-ECE5-4216-9D10-73A068E5C773Q47171869-BCAC8146-5126-44ED-AFEA-40FEF8C2A34EQ53411375-322B137D-A172-4B6E-8AEB-E3DE4B39AE29
P2860
Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@ast
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@en
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@nl
type
label
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@ast
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@en
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@nl
prefLabel
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@ast
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@en
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@nl
P2093
P2860
P356
P1476
Mechanism-based cancer prevent ...... nd the use of transgenic mice.
@en
P2093
DiGiovanni J
Fischer SM
Hursting SD
P2860
P304
P356
10.1093/JNCI/91.3.215
P407
P577
1999-02-01T00:00:00Z